Skip to main content
SpringerLink
Log in

Optimum Treatment of Streptococcal Pharyngitis

  • Disease Management
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Streptococcal pharyngitis is a common infection in children and adolescents. The great majority of these infections are caused by group A β-haemolytic streptococci.

Although the use of penicillins for group A β-haemolytic streptococcal pharyngitis has reduced the incidence of rheumatic fever, in the past decade several studies of pharyngitis treatment have reported penicillin failure. It has also been suggested that in comparison with the penicillins the cephalosporins are associated with a lower rate of clinical failure. Cephalosporins have drawbacks in cost, administration frequency or adverse effect profile. Moreover, there is the theoretical risk of cross-antigenicity to cephalosporins in penicillin-allergic patients.

Erythromycin is a traditional alternative to penicillins, especially in penicillin-allergic patients, for the treatment of tonsillopharyngitis. However, increased resistance as well as failure rates as high as 24.7% have been reported for erythromycin in the treatment of pharyngitis.

Therefore oral penicillins, and alternatively oral cephalosporins, should be considered first-line agents for the treatment of culture-confirmed group A β-haemolytic streptococcal tonsillopharyngitis. Cephalosporins are useful especially for the treatment of recurrent streptococcal tonsillopharyngitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Evans AS, Dick EC. Acute pharyngitis and tonsillitis in University of Wisconsin students. JAMA 1964; 190: 699–708

    Article  PubMed  CAS  Google Scholar 

  2. Putto A. Febrile or exudative tonsillitis: viral or streptococcal?. Pediatrics 1987; 80: 6–11

    PubMed  CAS  Google Scholar 

  3. Conference de Consensus organisée par l’ AFORCOPI (Association pour la Formation Continue en Pathologie Infectieuse): le traitement des angines aiguës et la prévention de leurs complications. Med Mal Infect 1991; 21: 277–84

    Google Scholar 

  4. Géhanno P, Pangon P, Moisy N, et al. Les angines: enquete épidémiologique. Med Mal Infect 1987; 17: 75–9

    Article  Google Scholar 

  5. Breese BB, Hall CB. Beta-hemolytic streptococcal diseases. Boston: Houghton Mifflin, 1978

    Google Scholar 

  6. Denny Jr FW. Group A streptococcal infections. Curr Probl Pediatr 1993; May/Jun: 17–85

    Google Scholar 

  7. Ryan DM, Cars O, Hoffstedt B. The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 1986; 18: 381–8

    Article  PubMed  CAS  Google Scholar 

  8. Schentag JJ. Clinical significance of antibiotic tissue penetration. Clin Pharmacokinet 1989; 16 Suppl. 1: 25–31

    Article  PubMed  CAS  Google Scholar 

  9. Roos K, Brorson J-E. Concentration of phenoxymethyl-penicillin in tonsillar tissue. Eur J Clin Pharmacol 1990 Oct; 39: 417–8

    Article  PubMed  CAS  Google Scholar 

  10. Shyu WC, Reilly J, Campbell DA. Penetration of cefprozil into tonsillar and adenoidal tissues. Antimicrob Agents Chemother 1993 May; 37: 1180–3

    Article  PubMed  CAS  Google Scholar 

  11. Fraschini F, Scalglione F, Vago F, et al. Correlation between plasma and tonsillar levels of cefroxadine. Chemotherapy 1988; 34: 8–12

    Article  PubMed  CAS  Google Scholar 

  12. Scaglione F, Falchi M, Ferrara F, et al. Cefonicid distribution into tonsillar tissue. Int J Clin Pharmacol Res 1990; 10: 265–70

    PubMed  CAS  Google Scholar 

  13. Gordin A, Mannisto PT, Antikainen R, et al. Concentrations of erythromycin 2’-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate. Antimicrob Agents Chemother 1988; 32(7): 1019–24

    Article  PubMed  CAS  Google Scholar 

  14. Fraschini F, Scaglione F, Pintucci G, et al. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother 1991 Feb; 27 Suppl. A: 61–5

    Article  PubMed  Google Scholar 

  15. Galioto GB, Ortisi G, Mevio E, et al. Roxithromycin disposition in tonsils after single and repeated administrations. Antimicrob Agents Chemother 1988; 32(9): 1461–3

    Article  PubMed  CAS  Google Scholar 

  16. Scaglione F, Falchi M, Nebuloni R, et al. Miocamycin distribution in tonsillar and pulmonary tissues after repeated administration. J Chemother 1990 Dec; 2: 384–9

    PubMed  CAS  Google Scholar 

  17. Pichichero ME, McLinn SE, Gooch WM III, et al. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Pediatr Infect Dis J 1995; 14: S102–7

    Article  PubMed  CAS  Google Scholar 

  18. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebo controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985; 253: 1271

    Article  PubMed  CAS  Google Scholar 

  19. Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis, 1984; 3: 10–3

    Article  PubMed  CAS  Google Scholar 

  20. Wannamaker LW. Changes and changing concepts in the biology of group A streptococci and in the epidemiology of streptococcal infections. Rev Infect Dis 1979; 1: 967–75

    Article  PubMed  CAS  Google Scholar 

  21. Gooch WM, McLinn SE, Aronovitz GH, et al. Efficacy of ce-furoxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob Agents Chemother 1993; 37: 159–63

    Article  PubMed  Google Scholar 

  22. Gooch WM, Swenson E, Higbee MD, et al. Cefuroxime axetil and penicillin V in the treatment of group A beta-hemolytic streptococcal pharyngitis. Clin Ther 1987; 9: 670–7

    PubMed  Google Scholar 

  23. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it?. Pediatr Infect Dis J 1993; 12: 268–74

    Article  PubMed  CAS  Google Scholar 

  24. Bass JW. Antibiotic management of Group A streptococcal pharyngotonsillitis. Pediatr Infect Dis J 1991; 10: S43–9

    Article  PubMed  CAS  Google Scholar 

  25. Cerstelotte E, Vandenbergher P, Bradbury F, et al. Cefetamet pivoxil and penicillin V in the treatment of group A beta-hemolytic streptococcal pharyngitis. Acta Ther 1990; 16: 163–73

    Google Scholar 

  26. Géhanno P, Chiche D. Traitement des angines à streptocoque beta-hémolytique du groupe A par le céfuroxime axetil pendant 4 jours: étude comparative a la pénicilline V pendant 10 jours. Med Mal Infect 1991; 21 Suppl.: 66–70

    Article  Google Scholar 

  27. Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and Augmentin in the treatment of upper respiratory tract infections. Drugs Exp Clin Res 1987; 13: 91–4

    PubMed  CAS  Google Scholar 

  28. Peyramond D, Tigaud S, Darchy L, et al., et le groupe de travail. Etude munticentrique comparant l’efficacité du céfixime pendant 4 jours a la phénoxyméthylpénicilline pendant 10 jours chez des patients ayant una angine à streptocoque beta-hémolytique du groupe A. Med Mal Infect 1993; 23 Suppl.: 419–26

    Article  Google Scholar 

  29. Portier H, Chavanet P, Gouyon JB, et al. Five-day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother 1990; 26 Suppl. E: 79–85

    Article  PubMed  Google Scholar 

  30. Shulman ST, Gerber MA, Tanz RR, et al. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J 1994; 13: 1–7

    PubMed  CAS  Google Scholar 

  31. Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngitis: reports of penicillin’s demise are premature. J Pediatr 1993; 123: 679–85

    Article  PubMed  CAS  Google Scholar 

  32. Natwani D, Wood MJ. Penicillins: a ccurrent review of their clinical pharmacology and therapeutic use. Drugs 1993; 45: 866–94

    Article  Google Scholar 

  33. Mandel GL, Petri Jr WA. Penicillins, cephalosporins and other beta-lactam antibiotics. In: Hardman JG, Limbird LE editors. Goodman and Gilman’s the pharmacological basis of theraputics. 9th ed. New York: McGraw-Hill, 1995: 1073–101

    Google Scholar 

  34. Breese Hall C, Gordon Douglas Jr CR. Infections of the upper respiratory tract, trachea and bronchi. In: Reese RE, Gordon Douglas R, editors. A practical approach to infections diseases. Boston, Toronto: Little Brown and Company 1986: 174–201

    Google Scholar 

  35. Stillerman M. Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatr Infect Dis J 1986; 5: 649–54

    Article  CAS  Google Scholar 

  36. Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr 1988; 113: 400–3

    Article  PubMed  CAS  Google Scholar 

  37. Ginsberg CM, McCracken Jr GH, Crow SD, et al. A controlled comparative study of penicillin V and cefadroxil therapy of group A streptococcal tonsillopharyngitis. J Int Med Res 1980; 8 Suppl. 1: 82–6

    Google Scholar 

  38. Gastanaduy AS, Huwe BB, Kaplan EL, et al. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; II: 498–502

    Article  Google Scholar 

  39. Smith TD, Huskins WC, Kim KS, et al. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr 1987; 110: 777–82

    Article  PubMed  CAS  Google Scholar 

  40. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991; 10: 2755–81

    Google Scholar 

  41. Hooton TM. A comparison of azithromycin and penicillin V for treatment of streptococcal pharyngitis. Am J Med 1991; 91 Suppl. 3A: 23–6

    Article  Google Scholar 

  42. Aujard N, Boucot I, Brahimi N, et al. Comparative efficacy and safety of four day cefuroxime axetil and ten day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children. Pediatr Infect Dis J 1995: 14: 295–300

    Article  PubMed  CAS  Google Scholar 

  43. Milatovic D, Adam D, Hamilton H, et al. Cefprozil versus Penicillin V treatment of streptococcal tonsillopharyngitis. Antimicrob Agents Chemother 1993; 37: 1620–3

    Article  PubMed  CAS  Google Scholar 

  44. Holm S, Henning C, Grahn E, et al. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis. Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. Scand J Infect Dis 1995; 27: 221–8

    Article  PubMed  CAS  Google Scholar 

  45. Still JG, Hubband WC, Poole JM, et al. Comparison of chlarythromycin and penicillin VK suspension in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies. Pediatr Infect Dis J 1993; 12: S34–41

    Google Scholar 

  46. Cotcher IS, Bass JW. Penicillin treatment of streptococcal pharyngitis: a comparison of schedule and the role of specific counseling. JAMA 1972; 222: 657–9

    Article  Google Scholar 

  47. Rosenstein BJ, Markowitz M, Goldstein E. Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. J Pediatr 1969; 73: 513–20

    Google Scholar 

  48. Backwell B. Drug therapy. N Engl J Med 1973; 249–52

    Google Scholar 

  49. Stromberg A, Schwan A, Cars O. Five versus ten days treatment of Group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988; 20: 37–46

    Article  PubMed  CAS  Google Scholar 

  50. Schwartz RH, Wientzen RL, Pedreira F, et al. Penicillin V for Group A streptococcal pharyngotonsillitis: a randomized trial of seven vs ten days’ therapy. JAMA 1981; 246: 1790–5

    Article  PubMed  CAS  Google Scholar 

  51. Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate Group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681–4

    Article  PubMed  CAS  Google Scholar 

  52. Grahn E, Holm SE, Roos K. Penicillin tolerance in betastrepto-cocci isolated from patients with tonsillitis. Scand J Infect Dis 1987; 19: 421–6

    Article  PubMed  CAS  Google Scholar 

  53. Roos K, Grahn E, Lind L, et al. Treatment of recurrent streptococcal tonsillitis by recolonization with alpha-streptococci. Eur J Clin Microbiol Infect Dis 1989; 8: 318–9

    Article  PubMed  CAS  Google Scholar 

  54. Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A streptococci. Pediatr Infect Dis J 1985; 5: 491–5

    Google Scholar 

  55. Brook I, Yocum P. Quantitative measurement of beta-lactamase in tonsils of children with recurrent tonsillitis. Acta Otolaryngol 1984; 98: 556–9

    Article  PubMed  CAS  Google Scholar 

  56. Turner K, Nord CE. Emergence of beta-lactamase-producing anaerobic bacteria in the tonsils during penicillin treatment. Eur J Clin Microbiol 1986; 5: 339–44

    Google Scholar 

  57. Sanders C, Nelsen G, Sanders E. Bacterial interference: II: epidemiological determinants of the antagonistic activity of the normal throat flora against Group A streptococci. Infect Immun 1977; 16: 599–603

    PubMed  CAS  Google Scholar 

  58. Grahn E, Holm SE. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an appartment house area. Zbl Bakteriol Hyg A 1983; 256: 72–9

    CAS  Google Scholar 

  59. Roos K, Grahn E, Holm SE, et al. Interfering alfa-streptococci as a protection against streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol 1993; 25: 141–8

    Article  PubMed  CAS  Google Scholar 

  60. Roos K, Holm SE, Grahn E, et al. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis 1993; 25: 31–6

    PubMed  CAS  Google Scholar 

  61. Grahn E, Holm SE. Penicillin concentration in saliva and its influence on bacterial interference. Scand J Infect Dis 1987; 19: 235–41

    Article  PubMed  CAS  Google Scholar 

  62. Kaplan EL, Johnson DR. Clinical and laboratory obscrivations: eradication of Group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr 1988; 113: 400–3

    Article  PubMed  CAS  Google Scholar 

  63. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A beta-hemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother 1989; 24: 227–33

    Article  PubMed  CAS  Google Scholar 

  64. Tanz RR, Shulman ST, Srola PA, et al. Lack of influence of beta-lactamase-producing flora on recovery of Group A streptococci after treatment of acute pharyngitis. J Pediatr 1990; 117: 859–63

    Article  PubMed  CAS  Google Scholar 

  65. Stillerman M, Isenberg HD, Moody M. Streptococcal pharyngitis therapy: comparison of cephalexin, phenoxy methyl penicillin, and ampicillin. Am J Dis Child 1972; 123: 457–61

    PubMed  CAS  Google Scholar 

  66. Quintilliani R. Efficacy of twice-daily regimen of cefadroxil in the treatment of respiratory tract infections. Drugs 1986; 32: 43–9

    Article  Google Scholar 

  67. Clinsburg CM, McCracken GH. A controlled comparative study of penicillin V and cefadroxil therapy of group A streptococcal tonsillopharyngitis. J Int Med Res 1980; 8: 82–6

    Google Scholar 

  68. Gerber MA. Streptococcal pharyngitis in children. Drugs 1986; 32: 29–32

    Article  PubMed  Google Scholar 

  69. Randolph MF. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis. Chemotherapy 1988; 34: 512–8

    Article  PubMed  CAS  Google Scholar 

  70. Pichichero ME, Disney FA, Aronovitz GH, et al. Randomized, single-blind evaluation of cefadroxil and phenoxy-methyl penicillin in the treatment of streptococcal pharyngitis. Antimicrob Agents Chemother 1987; 31: 903–6

    Article  PubMed  CAS  Google Scholar 

  71. McLin SE. Cefaclor in treatment of otitis media and pharyngitis in children. Am J Dis Child 1980; 134: 560–3

    Google Scholar 

  72. Levine LR. Quantitative comparison of adverse reactions to cefaclor vs. amoxicillin in a surveillance study. Pediatr Infect Dis J 1985; 4: 358–61

    Article  CAS  Google Scholar 

  73. Heckbert BR, Striker WS, Coldn KL, et al. Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population. Am J Epidemiol 1990; 132: 336–42

    PubMed  CAS  Google Scholar 

  74. Dajani AS, Kessler SL, Medelson R, et al. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis. Pediatr Infect Dis J 1993; 12: 275–9

    Article  PubMed  CAS  Google Scholar 

  75. Brogden RN, Compoli-Richards DM. Cefixime: a review of its antibacterial activity: pharmacokinetic properties and therapeutic potential. Drugs 1989; 38: 524–50

    Article  PubMed  CAS  Google Scholar 

  76. Block SL, Hedrich JA, Tyler RD. Comparative study of the effectiveness of cefixime and penicillin V for treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J 1993; 11: 919–25

    Google Scholar 

  77. Derrick CW, Reilly KM, Stallworth JR. Erythromycin in the treatment of streptococcal infections. Pediatr Infect Dis J 1986; 5: 172–6

    Article  Google Scholar 

  78. Milatovic D. Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis. Pediatr Infect Dis J 1991; 10: S61–3

    Article  PubMed  CAS  Google Scholar 

  79. Disney FA, Downton MI, Higgins JE, et al. Comparison of once-daily cefadroxil and four-times-daily erythromycin in Group A streptococcal pharyngitis. Adv Ther 1990; 7: 312–26

    Google Scholar 

  80. Ginsberg CM, McCracken Jr GH, Crow SD, et al. Erythromycin therapy for Group A steptococcal pharyngitis. Am J Dis Child 1984; 138: 536–9

    Google Scholar 

  81. Janicki RS, Gamham JC, Worland MC, et al. Comparison of erythromycin ethyl succinate, stearate and estolate treatment group A streptococcal infections of the upper respiratory tract. Clin Pediatr 1975; 14: 1098–107

    CAS  Google Scholar 

  82. Washington JA, Wilson WR. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (first of two parts). Mayo Clin Proc 1985; 60: 189–203

    Article  PubMed  CAS  Google Scholar 

  83. Ball AP. Therapeutic considerations for the management of respiratory tract infection: the role of new macrolides and fluoroquinolones. Infec Med 1991; 8 Suppl. A: 7–17

    Google Scholar 

  84. Jones RM. In vitro activity of new macrolides against respiratory pathogens. Infect Med 1992; 9 Suppl. A: 13–9

    Google Scholar 

  85. Bachand Jr RT. A comparative study of clarithromycin and penicillin VK in the treatment of out patients with streptococcal pharyngitis. J Antimicrob Chemother 1991; 27 Suppl. A: 75–82

    Article  PubMed  Google Scholar 

  86. Still JG. Azithromycin suspension versus penicillin V suspension in the treatment of children with streptococcal pharyngitis. Clin Pharmacol Ther 1993; 53: 195

    Google Scholar 

  87. Zackrisson G, Lind L, Ross K, et al. Erythromycin resistant beta-hemolytic streptococci Group A in Goteborg, Sweden. Scand J Infect Dis 1988; 20: 419–20

    Article  PubMed  CAS  Google Scholar 

  88. Stingemore N, Francis GRJ, Toohey M, et al. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust 1989; 150: 626–31

    PubMed  CAS  Google Scholar 

  89. Phillips G, Parratt D, Orange GV, et al. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother 1990; 25: 723–4

    Article  PubMed  CAS  Google Scholar 

  90. Seppala H, Nissinen A, Jarvinene H, et al. Resistance to erythromycin in Group A streptococci. N Engl J Med 1992; 326: 292–7

    Article  PubMed  CAS  Google Scholar 

  91. Rathore MH, Jenkins SG. Group A beta-hemolytic Streptococcus: issue of resistance. Pediatr Infect Dis J 1993; 12: 354–5

    Article  PubMed  CAS  Google Scholar 

  92. Betriu C, Sanchez A, Gomez M, et al. Antibiotic susceptibility of Group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother 1993; 37: 1717–9

    Article  PubMed  CAS  Google Scholar 

  93. Maruyama S, Yoshioka H, Fujita K, et al. Sensitivity of Group A streptococci to antibiotics: prevalence of resistance to erythromycin in Japan. Am J Dis Child 1979; 133: 1143–5

    PubMed  CAS  Google Scholar 

  94. Fujita K, Murono K, Yoshikawa M, et al. Decline of erythtomycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1975–8

    Google Scholar 

  95. Frieden TR, Mangi RJ. Inappropriate use of oral ciprofloxacin. JAMA 1990; 264: 1438–40

    Article  PubMed  CAS  Google Scholar 

  96. Breese BB, Disney FA, Talpey WB, et al. Beta-hemolytic streptococcal infection: comparison of penicillin and lincomycin in the treatment of recurrent infections or the carrier state. Am J Dis Child 1969; 117: 147–52

    PubMed  CAS  Google Scholar 

  97. Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis: III Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin). Del Med J 1970; 42: 87–91

    PubMed  CAS  Google Scholar 

  98. Orrling A, Stjiemquist-Desatnik A, Schalen C, et al. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 1994; 26: 535–41

    Article  PubMed  CAS  Google Scholar 

  99. Jensen JH, Larsen SB. Treatment of recurrent acute tonsillitis with clindamycin: an alternative to tonsillectomy?. Clin Otolaryngol 1991; 16: 498–500

    Article  PubMed  CAS  Google Scholar 

  100. Tanz RR, Poncher JR, Corydon KE, et al. Clindamycin treatment of chronic pharyngeal carriage of Group a streptococci. J Pediatr 1991; 119–123: 8

    Google Scholar 

  101. Chead S, Bilinsky SA, Hennessy JL, et al. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of ten days penicillin vs. 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr 1985; 106: 481–6

    Article  Google Scholar 

  102. Tanz RR, Shulman ST, Barthel MJ, et al. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 1985; 106: 876–80

    Article  PubMed  CAS  Google Scholar 

  103. Brook I. Penicillin for streptococcal pharyngitis. J Pediatr 1985; 107: 825–6

    PubMed  CAS  Google Scholar 

  104. Brook I. The role of beta-lactamase producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601–7

    Article  PubMed  CAS  Google Scholar 

  105. Levine BB. Antigenicity and cross-reactivity of penicillins and cephalosporins. J Infect Dis 1973; 128: S364–6

    Article  PubMed  Google Scholar 

  106. Saxon A, Hassner A, Swabb EA, et al. Lack of cross-reactivity between aztreonam, a monobactam antibiotic, and penicillin in penicillin allergic subjects. J Infect Dis 1984; 149: 16–22

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Milan, via Vanvitelli 32, 20129, Milano, Italy

    Francesco Scaglione, Germana Demartini & Mauro M. Arcidiacono

  2. ENT Division, Vimercate Hospital, Milan, Italy

    Jean P. Pintucci

Authors
  1. Francesco Scaglione
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Germana Demartini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mauro M. Arcidiacono
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean P. Pintucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scaglione, F., Demartini, G., Arcidiacono, M.M. et al. Optimum Treatment of Streptococcal Pharyngitis. Drugs 53, 86–97 (1997). https://doi.org/10.2165/00003495-199753010-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199753010-00006

Keywords

Search

Navigation